Minerva Neurosciences (NERV) Free Cash Flow (2013 - 2026)
Minerva Neurosciences posted quarterly Free Cash Flow of -$5.4 million for Q1 2026, down 32.61% year-on-year from -$8.0 million in Q1 2025, and down 19.71% on a QoQ basis from -$4.5 million in Q4 2025.
Minerva Neurosciences (NERV) has 14 years of Free Cash Flow data on file, last reported at -$5.4 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow fell 32.61% year-over-year to -$5.4 million; the trailing twelve-month figure through Mar 2026 stood at -$14.8 million (up 15.34% YoY), and the FY2025 full-year result was -$13.5 million, up 30.89% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$5.4 million, down from -$4.5 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$115407.0 in Q1 2023 and bottomed at -$9.5 million in Q3 2022.
- The 5-year median for Free Cash Flow is -$4.5 million (2025), against an average of -$4.6 million.
- The widest annual swing landed in 2023, when Free Cash Flow soared 98.01%; it then plunged 5180.68% in 2024.
- A 5-year view of Free Cash Flow shows it stood at -$4.1 million in 2022, then sank by 45.77% to -$6.0 million in 2023, then increased by 13.76% to -$5.2 million in 2024, then grew by 12.69% to -$4.5 million in 2025, then dropped by 19.71% to -$5.4 million in 2026.
- The last three Free Cash Flow figures came in at -$5.4 million (Q1 2026), -$4.5 million (Q4 2025), and -$2.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Minerva Neurosciences | 215.11 Mn | 215.11 Mn | - | -5.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.40 Mn |
| Mar 31, 2026 | -5.40 Mn |
| Dec 31, 2025 | -4.51 Mn |
| Dec 31, 2025 | -4.51 Mn |
| Sep 30, 2025 | -2.90 Mn |
| Sep 30, 2025 | -2.90 Mn |
| Jun 30, 2025 | -2.03 Mn |
| Jun 30, 2025 | -2.03 Mn |
| Mar 31, 2025 | -4.07 Mn |
| Mar 31, 2025 | -4.07 Mn |
| Dec 31, 2024 | -5.17 Mn |
| Dec 31, 2024 | -5.17 Mn |
| Sep 30, 2024 | -4.35 Mn |
| Sep 30, 2024 | -4.35 Mn |
| Jun 30, 2024 | -3.94 Mn |
| Jun 30, 2024 | -3.94 Mn |
| Mar 31, 2024 | -6.09 Mn |
| Mar 31, 2024 | -6.09 Mn |
| Dec 31, 2023 | -5.99 Mn |
| Dec 31, 2023 | -5.99 Mn |
| Sep 30, 2023 | -4.81 Mn |
| Sep 30, 2023 | -4.81 Mn |
| Jun 30, 2023 | -3.87 Mn |
| Jun 30, 2023 | -3.87 Mn |
| Mar 31, 2023 | -115,407.00 |
| Mar 31, 2023 | -115,407.00 |
| Dec 31, 2022 | -4.11 Mn |
| Dec 31, 2022 | -4.11 Mn |
| Sep 30, 2022 | -9.53 Mn |
| Sep 30, 2022 | -9.53 Mn |
| Jun 30, 2022 | -5.19 Mn |
| Jun 30, 2022 | -5.19 Mn |
| Mar 31, 2022 | -5.81 Mn |
| Mar 31, 2022 | -5.81 Mn |
| Dec 31, 2021 | -4.83 Mn |
| Dec 31, 2021 | -4.83 Mn |
| Sep 30, 2021 | -8.63 Mn |
| Sep 30, 2021 | -8.63 Mn |
| Jun 30, 2021 | -5.92 Mn |
| Jun 30, 2021 | -5.92 Mn |
| Mar 31, 2021 | -5.22 Mn |
| Mar 31, 2021 | -5.22 Mn |
| Dec 31, 2020 | -7.16 Mn |
| Dec 31, 2020 | -7.16 Mn |
| Sep 30, 2020 | -9.87 Mn |
| Sep 30, 2020 | -9.87 Mn |
| Jun 30, 2020 | -7.59 Mn |
| Jun 30, 2020 | -7.59 Mn |
| Mar 31, 2020 | -9.20 Mn |
| Mar 31, 2020 | -9.20 Mn |
| Dec 31, 2019 | -14.18 Mn |
| Dec 31, 2019 | -14.18 Mn |
| Sep 30, 2019 | -9.52 Mn |
| Sep 30, 2019 | -9.52 Mn |
| Jun 30, 2019 | -10.13 Mn |
| Jun 30, 2019 | -10.13 Mn |
| Mar 31, 2019 | -9.60 Mn |
| Mar 31, 2019 | -9.60 Mn |
| Dec 31, 2018 | -9.80 Mn |
| Dec 31, 2018 | -9.80 Mn |
| Sep 30, 2018 | -9.98 Mn |
| Sep 30, 2018 | -9.98 Mn |
| Jun 30, 2018 | -11.23 Mn |
| Jun 30, 2018 | -11.23 Mn |
| Mar 31, 2018 | -10.93 Mn |
| Mar 31, 2018 | -10.93 Mn |
| Dec 31, 2017 | -8.91 Mn |
| Dec 31, 2017 | -8.91 Mn |
| Sep 30, 2017 | 24.89 Mn |
| Sep 30, 2017 | 24.89 Mn |
| Jun 30, 2017 | -6.84 Mn |
| Jun 30, 2017 | -6.84 Mn |
| Mar 31, 2017 | -6.04 Mn |
| Mar 31, 2017 | -6.04 Mn |
| Dec 31, 2016 | -8.93 Mn |
| Dec 31, 2016 | -8.93 Mn |
| Sep 30, 2016 | -4.66 Mn |
| Sep 30, 2016 | -4.66 Mn |
| Jun 30, 2016 | -6.05 Mn |
| Jun 30, 2016 | -6.05 Mn |
| Mar 31, 2016 | -6.05 Mn |
| Mar 31, 2016 | -6.05 Mn |
| Dec 31, 2015 | -6.60 Mn |
| Dec 31, 2015 | -6.60 Mn |
| Sep 30, 2015 | -5.73 Mn |
| Sep 30, 2015 | -5.73 Mn |
| Jun 30, 2015 | -7.03 Mn |
| Jun 30, 2015 | -7.03 Mn |
| Mar 31, 2015 | -4.91 Mn |
| Mar 31, 2015 | -4.91 Mn |
| Dec 31, 2014 | -5.03 Mn |
| Dec 31, 2014 | -5.03 Mn |
| Sep 30, 2014 | -27.16 Mn |
| Sep 30, 2014 | -27.16 Mn |
| Jun 30, 2014 | -2.54 Mn |
| Jun 30, 2014 | -2.54 Mn |
| Mar 31, 2014 | -1.24 Mn |
| Mar 31, 2014 | -1.24 Mn |
| Dec 31, 2013 | -1.21 Mn |
| Dec 31, 2013 | -1.21 Mn |
| Sep 30, 2013 | -381,703.00 |
| Sep 30, 2013 | -381,703.00 |